Yi-Bin ChenSteering Committee Member

Yi-Bin Chen is the Director of the Hematopoietic Cell Transplant and Cell Therapy Program and holds the Allen B. Rogers, Jr. and Cara J. Rogers Endowed Chair at Massachusetts General Hospital, Boston, US. In addition, he is an Associate Professor of Medicine at Harvard Medical School, Boston, US.

Chen earned his BS/MS in molecular biophysics and biochemistry from Yale University, New Haven, US, followed by obtaining his medical degree from Harvard Medical School. He completed his internship and residency at Massachusetts General Hospital, where he also served as chief medical resident. He then completed a fellowship in hematology and oncology at the Dana-Farber Brigham Cancer Center, Boston, US, combined program.

Chen’s research focuses on improving the outcomes of patients undergoing bone marrow transplantation (BMT). He has served as an investigator or principal investigator for many clinical trials involving numerous aspects of BMT, including conditioning regimens, alternative graft sources, novel treatments and prophylactic approaches for acute and chronic graft-versus-host disease, and the use of maintenance therapies after BMT.